Two novel 18-metallacrown-6 complexes: Synthesis, structural characterization and bioactivity

Bis[μ-N'-(2-methyl-1-oxidopropanyl-idene)-2-oxidobenzohydrazidato]tetra-pyridine-trinickel(II)

The asymmetric unit of the title trinuclear Ni(II) compound, [Ni(3)(C(11)H(11)N(2)O(3))(C(5)H(5)N)(4)], contains two independent mol-ecules which are located on individual inversion centres. The central Ni atom, located on an inversion centre, is coordinated by two pyridine N atoms and is further N,O-chelated by two N-(2-methyl-propano-yl)salicyloylhydrazidate anions in an elongated octa-hedral coordination geometry. The terminal Ni atom is coordinated by a pyridine ligand and is further N,N',O-chelated by an N-(2-methyl-propano-yl)salicyloyl-hydrazidate anion in a distorted square-planar coordination geometry. Weak intra-molecular C-H⋯O hydrogen bonding is observed in the structure.

New asymmetric heptaaza Schiff base macrocyclic complex of Mn(II): Crystal structure, biological and DFT studies

A new asymmetric heptaaza Schiff base macrocyclic bis(pendant donor) manganese(II) complex, [MnL(1)](ClO(4))(2).CH(3)CN (1), has been prepared and characterized by X-ray diffraction and spectroscopic methods. The antimicrobial activity of 1 and a series of its familiar symmetric heptaaza [15]pydieneN(5), [16]pydieneN(5), and [17]pydieneN(5)-based bis-(2-aminoethyl) pendant armed Schiff base macrocyclic complexes of Mn(II) were tested against Escherichia coli, Staphylococcus aureus and Candida albicans. The results showed that the symmetric heptaaza [16]pydieneN(5), and [17]pydieneN(5)-based Schiff base macrocyclic complexes of Mn(II) had remarkable inhibition zone on the culture of S. aureus and E. coli as compared with standard drugs. The optimized geometry of the prepared complex has been obtained from density functional method, DFT, using B3LYP/6-31G* basis set.